Aura Biosciences, Inc. AURA
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-10-29
Aura Biosciences, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 3,005,362 | $22.7M | 4.73% |
| MILLENNIUM MANAGEMENT LLC | 617,467 | $4.4M | 0.97% |
| RENAISSANCE TECHNOLOGIES LLC | 174,200 | $1.2M | 0.27% |
| AQR CAPITAL MANAGEMENT LLC | 109,889 | $780,213 | 0.17% |
| D. E. Shaw & Co., Inc. | 67,405 | $478,576 | 0.11% |
| CITADEL ADVISORS LLC | 51,902 | $368,504 | 0.08% |
| Point72 Asset Management, L.P. | 17,864 | $126,834 | 0.03% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.